Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Daily News

Structural Heart Disease Imagers Call for Greater Recognition, Focused Training

Yael L. Maxwell

October 03, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

Presentation JIM 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

Presenter: Azeem Latib

February 10, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for April 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

The Biggest News of 2022: TCTMD’s Top 10

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Structural Heart Disease Imagers Call for Greater Recognition, Focused Training

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

TCTMD’s Top 10 Most Popular Stories for June 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular Stories for February 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content